PCA
Personal Capital Advisors Portfolio holdings
AUM
$20.6B
This Quarter Return
+4.25%
1 Year Return
-13.65%
3 Year Return
+17.55%
5 Year Return
+33.04%
10 Year Return
–
AUM
$1.83B
AUM Growth
+$1.83B
(+20%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
14.04%
Top 10 Holdings %
Top 10 Hldgs %
38.64%
Holding
168
New
17
Increased
122
Reduced
12
Closed
9
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$39.4M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$36.3M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$35.8M |
| 4 |
Schwab International Equity ETF
SCHF
|
$17.2M |
| 5 |
Apple
AAPL
|
$11.9M |
Top Sells
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
$26.5M |
| 2 |
EMC
EMC CORPORATION
EMC
|
$11.1M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$8.01M |
| 4 |
AWAY
HOMEAWAY INC COM
AWAY
|
$5.92M |
| 5 |
Equifax
EFX
|
$4.69M |
Sector Composition
| 1 | Industrials | 6.6% |
| 2 | Communication Services | 6.55% |
| 3 | Financials | 5.48% |
| 4 | Healthcare | 4.6% |
| 5 | Consumer Discretionary | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BV
151
DELISTED
Bazaarvoice, Inc.
BV
| $76K | ﹤0.01% |
17,376
| – | – |
|
152
SiriusXM
SIRI
$7.92B
| $58K | ﹤0.01% |
14,364
-5,467
| -28% | -$22.1K |
|
|
IMBI
153
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $36K | ﹤0.01% |
20,443
| – | – |
|
|
ENG
154
DELISTED
ENGlobal Corp
ENG
| $17K | ﹤0.01% |
17,537
| – | – |
|
|
ELI
155
DELISTED
ELITE PHARMACEUTICAL
ELI
| $10K | ﹤0.01% |
25,000
| – | – |
|
|
SD
156
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $5K | ﹤0.01% |
26,750
| – | – |
|
|
FRP
157
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
| – | – |
-17,518
| Closed | – |
|
|
AWAY
158
DELISTED
HOMEAWAY INC COM
AWAY
| – | – |
-222,949
| Closed | -$5.92M |
|
|
EMC
159
DELISTED
EMC CORPORATION
EMC
| – | – |
-461,040
| Closed | -$11.1M |
|
160
Vera Bradley
VRA
$58.7M
| – | – |
-336,201
| Closed | -$4.24M |
|
161
Invesco S&P 500 Equal Weight ETF
RSP
$73.5B
| – | – |
-8,143
| Closed | -$599K |
|
162
Altria Group
MO
$112B
| – | – |
-4,575
| Closed | -$249K |
|
163
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-4,910
| Closed | -$291K |
|